This image shows that the 90th ATA annual meeting will be virtual and held on September 30 to October 3 2021.

Plenary Speakers

33

Gregory A. Brent, MD

Gregory A. Brent, MD
NIS: The Basis of 80 Years of Radioiodine Therapy in Benign and Malignant Disease

Nancy Carrasco, MD
NIS: The journey since its cloning 25 years ago

Antonio Di Cristofano, PhD

Antonio Di Cristofano, PhD
Year in Thyroidology – Recent Developments and Future Challenges: Basic Science Review

Emad Kandil, MD

Emad Kandil, MD
Disparities in Surgical Management of Thyroid Disease

Megan Haymart, MD

Megan Haymart, MD
Year in Thyroidology – Recent Developments and Future Challenges: Clinical Science Review

Donald S. A. McLeod, MBBS, MPH, PhD

Donald S. A. McLeod, MBBS, MPH, PhD
Disparities in Thyroid Care: Bridging the Gaps

 

Julie Ann Sosa, MD

Julie Ann Sosa, MD
Disparities in Differentiated Thyroid Cancer Care

Ralph Tufano, MD

Ralph Tufano, MD
Year in Thyroidology – Recent Developments and Future Challenges: Surgical Review

Symposium Speakers

Takashi Akamizu, MD

Takashi Akamizu, MD
Thyroid Storm: Myths and Facts

Fereidoun Azizi, MD

Fereidoun Azizi, MD
Long Term ATD – Is it a Better Way?

Giuseppe Barbesino, MD

Giuseppe Barbesino, MD
Clinical Update in Thyroid Autoimmunity

Antonio Bianco, MD, PhD

Antonio Bianco, MD, PhD
New Formulations of Liothyronine

Keith Bible, MD, PhD

Keith Bible, MD, PhD
Update in Management of Anaplastic Thyroid Cancer: 2021 ATA Guidelines

Kristien Boelaert, MD, PhD

Kristien Boelaert, MD, PhD
Preconception Counselling and Care for Pregnant Women with Autoimmune Thyroid Disease

Laura Boucai, MD

Laura Boucai, MD
Management of Recurrent Thyroid Cancer

Myriem Boufraqech, PhD

Myriem Boufraqech, PhD
Glutamine Metabolism is a new Therapeutic Target in Thyroid Cancer

JP Brito, MD

JP Brito, MD
Initial Data from ATA and ETA Member Survey on Thyroid Eye Disease

Henry Burch, MD

Henry Burch, MD
Overview of the ATA/ETA Collaboration Developing a  Statement Regarding the Management of Thyroid Eye Disease

Kenneth Burman, MD

Kenneth Burman, MD
Lewis E. Braverman Award Lecture

Maria Cabanillas, MD

Maria Cabanillas, MD
Current and Upcoming Clinical Trials in Thyroid Cancer

Frances Carr, PhD

Frances Carr, PhD
T-3 dependent Epigenetic Coordination by TR

Sheue-yann Cheng, PhD

Sheue-yann Cheng, PhD
Valerie Anne Galton Award Lecture

Oliver Clarke, PhD

Oliver Clarke, PhD
Structure Determination of Mammalian Thyroglobulin by cryoEM

David Cooper, MD

David Cooper, MD
Clark T. Sawin Historical Vignette: Edwin B. Astwood and the Development of the Antithyroid Drugs

Francesca Coscia PhD

Francesca Coscia PhD
Basic/Translational Update of Autoimmune Thyroiditis

Colin Dayan, MA, FRCP, PhD

Colin Dayan, MA, FRCP, PhD
Hypothyroidism: Clinical Trials Underway

Robert Denver, PhD

Robert Denver, PhD
Thyroid Hormone Induction of DNA Demethylation in Developing Brain

Alexandra Dumitrescu, MD, PhD

Alexandra Dumitrescu, MD, PhD
Loss-of-Function Mutations of DIO1

James Fagin, MD

James Fagin, MD
Pathophysiology of Radioiodine-Refractory DTC

Gary Francis, MD, PhD

Gary Francis, MD, PhD
Update on Thyroid Hormone Replacement in Children: Is There a Role for T3 or Newer Formulations?

Suzanne Freitag, MD

Suzanne Freitag, MD
Is surgical management of TED changing with available medical options?

Laura Fugazzola, MD

Laura Fugazzola, MD
The Spectrum of Thyroid Function Abnormalities in COVID-19 Patients

Thomas Giordano, MD, PhD

Thomas Giordano, MD, PhD
Pathology Perspectives on Molecular Testing and Personalized Thyroid Cancer Therapy

Melanie Goldfarb, MD

Melanie Goldfarb, MD
Challenges and Considerations in the Care of ATAs with Thyroid Cancer

John Glod, MD, PhD

John Glod, MD, PhD
Medical Therapies for Medullary Thyroid Cancer in Children

Bryan Haugen, MD

Bryan Haugen, MD
Pembrolizumab and Lenvatinib – A Powerful Duo in Differentiated and Undifferentiated Thyroid Cancer

Jerome Hershman, MD

Jerome Hershman, MD
Clark T. Sawin Historical Vignette: Edwin B. Astwood and the Development of the Antithyroid Drugs

Mimi Hu, MD

Mimi Hu, MD
Clinical Perspectives on Molecular Testing and Personalized Thyroid Cancer Therapy

David Ingbar, MD

David Ingbar, MD
Treatment of SARS with L-T3

Yasuhiro Ito, MD, PhD

Yasuhiro Ito, MD, PhD
Active Surveillance: Experience and Lessons Learned

Susan Jordan, PhD

Susan Jordan, PhD
Global Trends in Thyroid Cancer Epidemiology: Is there Evidence of a True Increase in Incidence

Jacqueline Jonklaas, MD, PhD

Jacqueline Jonklaas, MD, PhD
How to Use LT3 + LT4 today

Brian Kim, MD

Brian Kim, MD
Thyrotoxic Conditions: Consideration for Surgery vs RAI Referral

Anupam Kotwal, MD

Anupam Kotwal, MD
Management of Endocrine Side Effects of Immunotherapy

Jennifer Kuo, MD

Jennifer Kuo, MD
Highlights of the Data on Ablation

Theodore Laetsch, MD

Theodore Laetsch, MD
Targeted Medical Therapies for Differentiated Thyroid Cancer in Children

Sophie Leboulleux, MD

Sophie Leboulleux, MD
Update on Redifferentiation Trials in Radioiodine-Refractory DTC

Melissa Lechner, MD

Melissa Lechner, MD
Analysis of Risk, Disparity and Outcomes in COVID-19 Patients with Thyroid Cancer

Angela Leung, MD, MSc

Angela Leung, MD, MSc
Issues in the Pregnant or Lactating Patient with Thyroid Cancer

Carla Moran, MB, PhD

Carla Moran, MB, PhD
Update on Syndromes of Resistance to Thyroid Hormone

Jose Moreno, MD, PhD

Jose Moreno, MD, PhD
Loss-of-Function Mutations of DIO2

Chris McCabe, PhD

Chris McCabe, PhD
New Insights into Regulation of NIS Expression and Function

Susanne Neumann, MD

Susanne Neumann, MD
What have we learned about the underlying molecular mechanisms in recent years?

Maria Papaleontiou, MD

Maria Papaleontiou, MD
Practical Considerations on Managing Thyroid Cancer in Older Adults

Petros Perros, MD

Petros Perros, MD
Overview of the ATA/ETA Collaboration Developing a  Statement Regarding the Management of Thyroid Eye Disease

Susan Pitt, MD

Susan Pitt, MD
Preop Management of the Thyrotoxic Patient, Operative Considerations and Challenges and Postop Challenges

Matthew Ringel, MD

Matthew Ringel, MD
Sidney H. Ingbar Award Lecture

Douglas Ross, MD

Douglas Ross, MD
Shifts in Treatment Preferences for Hyperthyroidism-Where we were, Where we are, and Where we’re going

Jonathon Russell, MD

Jonathon Russell, MD
Surgical Considerations for Small Primary DTC

Domineco Salvatore, MD, PhD

Domineco Salvatore, MD, PhD
Syndromes of DIO3 Reactivation

Mario Salvi, MD

Mario Salvi, MD
Novel medical therapies for TED – what and when?

Manisha Shah, MD

Manisha Shah, MD
Targeted Therapies in DTC and MTC: Where Have we Started and What Have we Achieved

Anu Sharma, MD

Anu Sharma, MD
Thyroid Lymphoma: A Diagnosis to consider in the Rapidly Enlarging Thyroid Mass

Padmanee Sharma, MD, PhD

Padmanee Sharma, MD, PhD
Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy for the Development of Rational Combination Therapies

Yun-Bo Shi, PhD

Yun-Bo Shi, PhD
Histone and DNA Modifications in Amphibians

David Shonka, MD

David Shonka, MD
Management of Recurrent Thyroid Cancer

Marius Stan, MD

Marius Stan, MD
Novel Medical Therapies for Thyroid Eye Disease – What and When?

David Steward, MD

David Steward, MD
Did my patient get appropriate nodal dissection?

Salvatore Vaccarella, PhD

Salvatore Vaccarella, PhD
Impact of Overdiagnosis on International Patters in Thyroid Cancer Incidence and Mortality

W. Edward Visser, MD, PhD

W. Edward Visser, MD, PhD
Diagnosis and Treatment of MCT8 Deficiency/Allan-Herndon-Dudley Syndrome

Steve Waguespack, MD

Steve Waguespack, MD
Perspectives From a Pediatric and Adult Endocrinologist: Advances and Gaps in Care Across the Age Spectrum

Cheuk Wun Li, PhD

Cheuk Wun Li, PhD
Novel Targeted Immunotherapies for Autoimmune Thyroid Diseases

Michael Yeh, MD

Michael Yeh, MD
Did my patient get appropriate nodal dissection?

Linwah Yip, MD

Linwah Yip, MD
Management of Recurrent Thyroid Cancer